NICOLE LORANG: Open Payments
NPI 1295110385 · GLENVIEW, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,158 in 203 payments from 34 companies in 2025. Trend: 2023 $3,994 · 2024 $4,185 · 2025 $5,158
Food & beverage: $5,158
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 21 | $771 |
| Lilly USA, LLC | 26 | $573 |
| Dexcom, Inc. | 10 | $487 |
| Ascensia Diabetes Care Us Inc. | 10 | $308 |
| Neurocrine BioSciences, Inc. | 8 | $278 |
| Novo Nordisk Inc | 10 | $246 |
| Mannkind Corporation | 8 | $233 |
| Amgen Inc. | 18 | $214 |
| Ascendis Pharma Endocrinology Inc | 10 | $186 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $174 |
Products named: Korlym, Dexcom G6 Transmitter, MOUNJARO, CRENESSITY, AFREZZA, Yorvipath, JARDIANCE, Kerendia.
Industry payments across IL — which companies pay providers there.
